caddra.ca

LinkedIn  X  Web

April 2024

Update

CADDRA is a Canadian non-profit member association for medical and health care professionals, along with researchers, who assess, treat and/or study ADHD.

Submissions Portal is Open!

Abstract submission deadline is

May 13, 2024 at 11:59pm (EDT)

There will be NO extension.

Submit an abstract

Add this Event to your Calendar

Keynote Speaker

Margaret D. Weiss, MD, PhD, FRCP(C), is Director of Neurodevelopmental Services at Cambridge Health Alliance and Associate Professor of Psychiatry at Harvard University. She has specialized in diagnosis, treatment, and research in ADHD, Sleep and Autism through the life cycle. She received her MD and Fellowship in Psychiatry from McGill University and her PhD in the History of Science from Harvard University.  Dr. Weiss has published over 160 articles, co-authored the current chapter on ADHD in the Comprehensive Textbook of Psychiatry and the book ADHD in Adulthood: A Guide to Current Theory, Diagnosis, and Treatment.  Dr. Weiss is known for her research on melatonin and sleep hygiene treatment in ADHD.  She is the author of the Weiss Functional Impairment Rating Scale, a widely used measure translated into fourteen languages. She has lectured in more than twenty-three countries. Dr. Weiss is a former CADDRA Board member and current vice-chair of the CADDRA Advisory Council.

Plan your downtime using this special CADDRA delegate microsite provided by Tourism Winnipeg.

Reserve your Accommodation!


CADDRA 2024 will be hosted at the convenient downtown location of the Fairmont Winnipeg in Winnipeg, Manitoba.

 

A limited block of rooms has been set aside at a special reduced rate for CADDRA 2024 attendees.


Reserve your room now!

Current ADHD Research

Please note: These are links to research abstracts. Some are available without cost and others require a subscription. 

Treatments for ADHD in Children and Adolescents: A Systematic Review. Peterson, Bradley S., et al. Pediatrics (2024): e2024065787.


Tools for the Diagnosis of ADHD in Children and Adolescents: A Systematic Review. Peterson, Bradley S., et al. Pediatrics (2024): e2024065854.


Subcortico-Cortical Dysconnectivity in ADHD: A Voxel-Wise Mega-Analysis Across Multiple Cohorts. Norman, Luke J., et al. American Journal of Psychiatry (2024): appi-ajp.

Suboptimal decision making and interpersonal problems in ADHD: longitudinal evidence from a laboratory task. Sørensen, L., et al. Scientific Reports 14.1 (2024): 6535.


One-year follow-up of the effectiveness and mediators of cognitive behavioural therapy among adults with attention-deficit/hyperactivity disorder: secondary outcomes of a randomised controlled trial. Pan, Mei-Rong, et al. BMC psychiatry 24.1 (2024): 207.


ADHD Pharmacotherapy and Mortality in Individuals With ADHD. Li, Lin, et al. JAMA 331.10 (2024): 850-860.

CADDRA ADHD and Substance Use Program

In last month’s newsletter, we shared perspectives of individuals with lived experience informing the development of the CADDRA ADHD and Substance Use Program (CASUP). This month, we wanted to share key research articles adding to the knowledge base underlying the CASUP content.

Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice.Chamakalayil, Sunsha, et al. Frontiers in psychiatry 11 (2021): 540837.

Systematic Review and Meta‐Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder. Fluyau, Dimy, Neelambika Revadigar, and Christopher G. Pierre. The American Journal on Addictions, 30.2 (2021): 110-121.

Managing Adult Attention-Deficit/Hyperactivity Disorder with Comorbid Substance Use Disorder.Ward, Burton, Anees Bahji, and David Crockford. Canadian Journal of Addiction 13.4 (2022): 6-12.

The course will launch in late 2024 on ADHDLearn. Complete this survey to receive advance email notification when the course launches.

Funding Opportunity

Physicians' Services Incorporated (PSI) Foundation is very pleased to launch the 2025 PSI Graham Farquharson Knowledge Translation (KT) Fellowship.


This Fellowship is intended to provide salary support for an early-career physician researcher in Ontario, who has demonstrated the ability to successfully complete high-impact knowledge translation research. 


Learn more.

Are you looking to earn CME Credits

Click here to see the accredited programs CADDRA has to offer on ADHDLearn.

Upcoming Events

CADDRA Exhibits. Meet us at:


31st Annual Rural & Remote Medicine Conference

April 18-20, 2024

Edmonton, AB


Canadian Paediatric Society Annual Conference

June 6-8, 2024

Vancouver, BC


Family Medicine Forum (FMF)

November 6-9, 2024

Vancouver, BC

Other Conferences of Note


UKAAN Conference 2024

UK Adult ADHD Network

April 16-18, 2024

London, England


HIDC: High Incidence Disabilities in Higher Education Conference

May 2-3, 2024

Toronto, ON


91e Congrès de l'Acfas

May 13-17, 2024

Virtual

Available on ADHDLearn

Online Courses


Canadian ADHD Practice Guidelines (free access for members)

Are You Professionally Involved with ADHD?

Discover the benefits of becoming a member of CADDRA.

FIND OUT MORE